2-(2-methoxyphenyl)-8-methylquinoline-4-carboxylic acid, 95.0%, 1g

(2S)-Oxiran-2-ylmethyl 4-methylbenzenesulfonate, 99.0%, 500g

3-(1h-Benzo[d]imidazol-2-yl)propan-1-amine dihydrochloride, 95+%, 25g

Methyl azetidine-3-carboxylate hydrochloride, 95.0%, 100g

5-(4-methoxyphenyl)-1,2,4-thiadiazol-3-amine, 95.0%, 250mg

Ethyl 1-(4-Fluorophenyl)-5-methyl-1H-pyrazole-4-carboxylate, 98.0%, 1g

benzyl 3-{[(4-methylphenyl)amino]carbonyl}piperidine-1-carboxylate, 5g

(2,5-Dimethyl-1,3-thiazol-4-yl)acetic acid, 97.0%, 10g

2-(((1S,2R,4S)-2-((tert-Butoxycarbonyl)amino)-4-(dimethylcarbamoyl)cyclohexyl)amino)-2-oxoacetic acid (Edoxaban Impurity), 97%, 50mg

2,3,6-Trifluorobenzoic Acid>98.0%(GC)(T)5g

Thallium standard solution, in 75 cSt mineral oil ROTI®Star, 50 g, plastic packaging.

2-(6-(4-(2-CHLORO-5-FLUOROPHENOXY)PIPERIDIN-1-YL)PYRIDAZIN-3-YL)-5-METHYL-1,3,4-OXADIAZOLE, 95%, 100mg

2,5,8,11-Tetraoxatridecan-13-ol, 95.0%, 5g